8-K - BIOMARIN PHARMACEUTICAL INC - 1.01 / 2.01 / 2.03 / 7.01 / 9.01

Form 8-K - Current report: SEC Accession No. 0001193125-26-179243

Filing Date: 2026-04-27

Accepted: 2026-04-27 08:45:12

Documents: 15

Period of Report: 2026-04-27

Items: Item 1.01: Entry into a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

BIOMARIN PHARMACEUTICAL INC (Filer) CIK : 0001048477 (see all company filings) EIN. : 680397820 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 26896784 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)

1 | 8-K | d113922d8k.htm iXBRL | 8-K

2 | EX-4.1 | d113922dex41.htm | EX-4.1

3 | EX-10.1 | d113922dex101.htm | EX-10.1

4 | EX-99.1 | d113922dex991.htm | EX-99.1